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A  method  for  creating  an  immobilized  capillary  tyrosinase  (TRS)  reactor  based  on a  layer-by-layer  (LBL)
assembly  for  inhibitor  screening  is described.  Tyrosinase  was  immobilized  on  the surface  of fused-silica
capillary  via  ionic  binding  technique  with  cationic  polyelectrolyte  hexadimethrine  bromide  (HDB).  Then,
HDB solution  with  the  same  plug  length  as  the  TRS  was  injected  again  into  the  capillary  to cover  the immo-
bilized  enzyme  by forming  HDB–TRS–HDB  sandwich-like  structure.  Then,  the substrate  of  l-tyrosine
was  introduced  into  the  capillary  and  on-line  enzyme  inhibition  study  was  performed  by capillary  elec-
trophoresis  (CE).  The enzyme  activity  was  determined  by the quantiﬁcation  of  peak  area  of  the  productmmobilized capillary enzyme reactor
nhibitor screening
atural extracts
apillary electrophoresis
of  l-DOPA.  Enzyme  inhibition  can  be read  out  directly  from  the  reduced  peak  area of the  product  in  com-
parison  with  a reference  electropherogram  obtained  in  the  absence  of  any  inhibitor.  The  immobilized
enzyme  could  withstand  25  consecutive  assays  by  only  losing  12%  activity.  A known  TRS  inhibitor,  kojic
acid  was  employed  as a model  compound  for the  validation  of  the  inhibitor  screening  method.  Finally,
screening  19  natural  extracts  of  traditional  Chinese  drugs  was  demonstrated.  The  results  indicated  that
e str
 2013inhibition  activity  could  b
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. Introduction
Development of screening methods to identify new, biologically
ctive compounds in natural extracts is a challenging task. Natu-
al extracts offer an extremely high level of molecular diversity,
hus providing an essential source of compounds for the discovery
f new drugs. Renewed interest in natural extract screening has
esulted from the development of new assays that detect low lev-
ls of bioactive molecules and modern analytical techniques that
nable isolation and characterization of minute amounts of active
ompounds.
Tyrosinase (TRS), a multifunctional type-3 copper-containing
etalloenzyme, is widely distributed in microorganism, plants
nd animals with slightly different forms [1]. It catalyzes two dis-
inct reactions of melanin biosynthesis: the o-hydroxylation of the
mino acid l-tyrosine to l-3,4-dihydroxyphenylalanine (l-DOPA),
nd the subsequent oxidation of l-DOPA to the corresponding
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o-dopaquinone, which is the rate-limiting step in the pathway [2,3].
Recent investigations showed that TRS are responsible not only for
the undesired enzymatic browning of fruits and vegetables but
also for the formation of various dermatological disorders, such
as freckles, melasma, ephelide and senile lentigines [4,5]. There-
fore, TRS inhibitors have become increasingly important in food
industry as well as in the medicinal and cosmetic products. In the
last decade, a large number of naturally occurring and synthetic
compounds acting as TRS inhibitors were reported [6–14]. Ultra-
violet spectrophotometry and ﬂuorescence spectra were used to
search the TRS inhibitors from various small-molecule compounds
and from Aloe vera [15,16]. In the reported TRS inhibitor screening
spectrophotometric methods, the enzyme and substrate reacted
under certain conditions, then detected products by UV–visible
spectrophotometry or ﬂuorescence. The inhibitory rate can be
quantiﬁed by the different peak areas of product in the presence
and absence of the inhibitors. The prominent advantages of this
method is simple equipment and easy to popularize. However, the
spectrophotometric assays have limitations such as consumption
of relatively large amount of enzyme, no possibility of automation,
etc. Therefore, more efforts are needed to search for TRS inhibitors
screening.
Open access under CC BY-NC-ND license.Recent trends have combined enzymatic assays with capil-
lary electrophoresis using regular capillary electrophoresis (CE)
instrument or microﬂuidics devices [17–19]. Such an approach
has several advantages resulting from the unique combination
D license.
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f features of CE including minimal sample requirements, high-
fﬁciency separation, and short analysis time. CE enzymatic assays
an be categorized into three formats depending on the step when
he enzymatic reaction takes place: pre-column, on-column and
ost-column. Electrophoretically mediated microanalysis (EMMA)
s a on-column CE-based technique. In EMMA,  solutions of substrate
nd enzyme are introduced in the capillary as distinct plugs. Upon
he application of a voltage, these two zones overlap each other due
o their different electrophoretic mobilities, and the enzyme reac-
ion takes place. Now, the EMMA  has been proved to be a useful tool
or enzyme assay and inhibition study [20–23]. The immobilized
nzyme-based screening method is a alternatively on-column CE-
ased technique. In this technique, the enzyme can be immobilized
o that it can be reusable. Various methods for creating the immo-
ilized capillary enzyme reactors in the format of capillaries or
icroﬂuidic chips have been reported [24–26]. In these reports, the
tudied enzymes can be covalently attached on the surface of the
onolithic bed or ﬁxed by sol–gel entrapment. The disadvantages
f these reports are losing enzyme activity and time-consuming.
ecently, a new approach was reported for creating immobilized
apillary enzyme reactors via ionic bonding. Because the con-
ition for ionic bonding is so mild, the enzyme activity can be
aximally preserved. The method displays advantages including
ery low cost and reusable enzyme. Tang and Kang prepared an
ngiotensin-converting enzyme reactor based on the ionic binding
mmobilization approach in the head of the capillary [27]. They
lso reported an acetylcholinesterase microreactor based on layer-
y-layer assembly technology for screening enzyme inhibitor [28].
hao et al. reported a new strategy using on-column immobilized
nzyme microreactor for screening adenosine deaminase (ADA)
nhibitors [29]. In their approach, ADA was encapsulated in anionic
olyelectrolyte alginate that was immobilized on the surface of
used-silica capillary with cationic polyelectrolyte polyethylen-
mine (PEI). In our previous work [30], we have reported the study
y using an electrophoretically mediated microanalysis (EMMA)
ethod for screening TRS inhibitors from traditional Chinese drugs.
The aim of the present work is to develop a simple on-column
mmobilized enzyme microreactor based CE method to screen TRS
nhibitors from traditional Chinese medicines. TRS was  immo-
ilized on the surface of fused-silica capillary via ionic binding
echnique with cationic polyelectrolyte hexadimethrine bromide
HDB). The property of inhibition kinetic of the immobilized TRS
as validated with a known TRS inhibitor (kojic acid), and the per-
ormance of the enzyme reactor was also evaluated. Furthermore,
he inhibitory ratios of enzymatic activity (IRE) of 20 traditional
hinese medicines were determined by the method.
. Experimental
.1. Apparatus and conditions
An Agilent HP3D capillary electrophoresis system (Agilent Corp.,
alo Alto, CA, USA) with DAD detector was used. Uncoated fused-
ilica capillary (Yongnian, Hebei Province, China) was  50 m
d × 60 cm in length and an effective length of 51.5 cm.  Data were
andled using HP Chemstation software. The voltage for separation
as −30 kV. The temperature of the capillary cartridge during elec-
rophoresis was maintained at 37 ◦C and the detector monitored at
14 nm.
.2. Materials and reagentsl-Tyrosine, mushroom tyrosinase (TRS) and hexadimethrine
romide (HDB) were obtained from Sigma (St. Louis, Mo,  USA).
he kojic acid and DOPA were purchased from Aladdin Chemicalnd Biomedical Analysis 84 (2013) 36– 40 37
Factory (Shanghai, PR China). All chemicals were of analytical-
reagent grade from Beijing Chemical Factory (Beijing, PR China).
Deionized water was  used throughout. All solutions and samples
were ﬁltered through 0.45 m syringe ﬁlter.
1.0 mg  mL−1 l-tyrosine was prepared in deionized water.
0.5 mg  mL−1 mushroom tyrosinase was diluted in 40 mM phos-
phate buffer (pH 7.4). The kojic acid solution (1.0 mg mL−1) was
prepared in deionized water. All solutions were ﬁltered through
a 0.45 m membrane ﬁlter and degassed by the same procedure.
Various concentrations of the sample solutions were prepared by
appropriate dilution from the stock solution with deionized water
and phosphate buffer.
These traditional Chinese medicines (1 g) were crushed and
dipped in 20 mL  distilled water, and then incubated on the elec-
tric hot plate (100 ◦C) for 1 h. After ﬁltered through a piece of
ﬁlter-paper, the ﬁltrates were condensed to dryness in a rotary
evaporator. The extracts were dissolved with 1 mL  of 40 mM  phos-
phate buffer.
2.3. Procedures for the immobilized capillary TRS reactor, activity
assay and inhibition study
The protocol for preparation of the immobilized capillary
enzyme reactor contains four steps as follow: (a) A new capillary
was pretreated by 0.1 M NaOH solution for 30 min  and followed by
rinsing with deionized water for 3 min. (b) A 0.1% w/v HDB aque-
ous solution was injected into the capillary and kept for 5 min to
create a positively charged coating on the capillary wall. (c) A plug
of 0.5 mg  mL−1 enzyme solution was  injected into the capillary by
pressure at 50 mbar for 10 s. (d) The 0.1% w/v  HDB solution with
almost the same length was injected into the capillary to cover
the immobilized enzyme by a layer of HDB. Once the function of
the immobilized enzyme reactor becomes poor, the immobilized
enzyme can be renewed conveniently by ﬂushing the capillary with
1 M NaCl, 0.1 M HCl, and 0.1 M NaOH, respectively, and then repeat-
ing the preparation protocol.
For activity assay and inhibition study, the capillary was  ﬁlled
with the running buffer (pH 7.4), consisting of 20 mM phosphate
and 0.01% HDB. The solutions of l-tyrosine in the presence and
absence of the inhibitors (kojic acid or natural extracts) were then
introduced by 50 mbar pressure for 10 s. After incubation for a short
time, −30 kV was applied to separate the product (l-DOPA) from
the unreacted substrate (l-tyrosine). The enzyme activities can be
quantiﬁed by the different peak areas of DOPA in the presence and
absence of the inhibitors.
3. Results and discussion
3.1. Preparation of the enzyme microreactor
TRS cannot be adsorbed on the inner surface of the fused-silica
capillary due to negatively charged at pH 7.4. So, it is necessary
to modify the capillary wall with a strong cation exchanger. In
this work, HDB was  used for modifying the capillary wall. The
schematic representation for the preparation of the immobilized
enzyme reactor is shown in Fig. 1. The stability comparison of the
immobilized enzyme reactors created by HDB layer-TRS- HDB layer
(LBL) and mono-HDB layer was investigated. The activity of the
immobilized enzyme created by the mono-HDB layer decreased
quickly with increase of the assay times. While, the activity of the
immobilized enzyme created by LBL assembly was kept constant.
So, an LBL strategy was  used to improve the strength of immobi-
lization. The stability of the enzyme reactor prepared by the LBL
assembly was  evaluated as follow: the substrate of l-tyrosine was
introduced into the capillary, after incubation and separation, the
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TFig. 1. Schematic representation of the immobilized
nzyme activities can be quantiﬁed by the peak areas of DOPA.
s shown in Fig. 2, it was found that relatively high stability of
he enzyme reactor was obtained by the LBL assembly. The activ-
ty of the immobilized enzyme decreased slowly with increase of
he assay times, and approximately 88% of the enzyme activity can
e conserved after 20 assays. The repeatability of the peak area of
he product (DOPA) in terms of run-to-run and batch-to-batch was
valuated, and RSD% (n = 6) were 2.8% and 4.7%, respectively. These
ata prove that our method for the preparation of the immobilized
nzyme reactor is not only simple but also robust.
.2. Optimization of CE conditionsOwing to the substrate and product exhibit an absorption max-
mum at 214 nm,  so 214 nm was selected as the detection. The
ffects of pH of electrolyte solution, concentration of phosphate
uffer, and the applied voltage on the separation were investigated.
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ig. 2. Stability of the immobilized capillary TRS reactor. CE condition: running
uffer, 20 mM phosphate (pH 7.4) consisting of 0.01% HDB; column temperature,
7 ◦C; sample injection, 50 mbar for 10 s; incubation time, 2 min; concentration of
RS, 0.5 mg mL−1; separation voltage, −30 kV.lary enzyme reactor prepared by the LBL assembly.
Because the TRS activity at pH 7.0–8.0 is highest, pH 7.4 was  cho-
sen for further optimization. Resolution between l-tyrosine, kojic
acid and DOPA was  enhanced with increasing borate buffer concen-
tration. But high buffer concentration will increase analysis time.
A higher applied voltage reduced the migration times due to an
increase of EOF. However, high applied voltage may  induce exces-
sive Joule heating which ruins the resolution and repeatability.
After a careful study, optimized CE conditions were as following:
20 mM phosphate (pH 7.4) consisting of 0.01% HDB and −30 kV
applied voltages.
3.3. Validation of the immobilized TRS reactor
Optimization of the incubation time on the yield of product
DOPA was investigated in Fig. 3. When incubated over 2 min, a
maximum yield could be achieved. So a 2 min  incubation time was
selected for further experiments.
Michaelis constant (Km) of the reaction was obtained under the
optimal conditions using ﬁve concentrations of l-tyrosine 0.17,
0.28, 0.39, 0.50 and 0.61 mM.  In the Michaelis–Menten plot, the
corrected DOPA peak areas were used to calculate initial reac-
tion velocity. The Km value of l-tyrosine was  determined to be
0.05334 mM by a Lineweaver–Burk plot. The value agreed with
the literature value obtained by photometric assay method and our
previous work [30].
In the study, kojic acid, a commercial tyrosinase inhibitor,
was employed as the model compound for the evaluation of this
method. A series of experiments were carried out with varied
concentrations of l-tyrosine ranging at each different concentra-
tion of kojic acid. The data from these experiments were plotted
by the method of Lineweaver–Burk as shown in Fig. 4. The plots
showed that kojic acid belonged to the mixed-mode inhibitor. The
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Fig. 3. Dependence of the yield of the reaction product on incubation time. Conditions as in Fig. 2.
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Table 1
The Inhibitory ratios of enzymatic activity for 19 different Chinese herbs.
Traditional Chinese medicines IRE% Traditional Chinese
medicines
IRE%
Caulis spatholobi 0 Perillaseed 0
Radix paeoniae rubra 0 Fructus crataegi 62.5
Semen alpiniae katsumadai 0 Raidix sanguisorbae 0
Radix glycytthizae 0 Pollen typhae 0
Rhizoma polygoni cuspidati 0 Radix angelicae
pubescentis
65
Folium mori 0 Radix et rhizoma rhei 0
Rhizoma phragmitis 0 Cortex eucommiae 0
Flos  caryophylli 0 Radix rehmanniae 0ig. 4. Lineweaver–Burk plots of kojic acid. The concentrations of kojic acid: (1)
0.4 M;  (2) 35.2 M;  (3) 0 M.  Other conditions same as in Fig. 2.
i inhibition constant for kojic acid was determined to be 24.54 M
y Dixon plot analysis, which agreed with the literature data [31].
.4. The inhibitory ratio of enzymatic activity (IRE) to tyrosinase
f the medicines
In order to eliminate the effect of l-tyrosine and l-DOPA on
he inhibition percentage, all of the 19 natural extracts were sepa-
ated by CE before screening. The results indicated that l-tyrosine
nd l-DOPA were not detected in all of the 19 natural extracts.
or the inhibition study and inhibitor screening, the l-tyrosine
olution containing inhibitors or certain natural extracts with the
nal concentration 0.02 mg  mL−1 was injected into the capillary.
he concentrations of the mushroom tyrosinase and the l-tyrosine
ere kept the same as above. The electropherograms of kojic acid
nd partial Chinese herbs for screening tyrosinase inhibitors are
hown in Fig. 5. The inhibitory ratios of enzymatic activity (IRE)
0 1 2 3 4 5 6
Fructus Crataegi
Radix Angeli cae Pubesce nti s
koji c acid
without inhibitor
3
2
1
Migrati on time  (min)
ig. 5. Electropherograms for screening the tyrosinase inhibitor. (1) DOPA, (2) kojic
cid  and (3) l-tyrosine. Conditions were as in Fig. 2.Fructus forsythiae 0 Galla chinensis 0
Radix codonopsis 0 kojic acid 57
of traditional Chinese medicines can be established, based on the
reduction of the peak area of the product DOPA. The percentage of
inhibition was  determined according to the following equation:
IRE = A(0) − A(i)
A(0)
× 100%
A(0) is the peak area value of DOPA after reaction without the
inhibitor, A(i)is the peak area value of DOPA after reaction with the
inhibitor.
To determine the inhibitory potency of tyrosinase inhibitor
with the developed in-capillary method, we compared the effect
of 19 traditional Chinese medicines at the same concentration of
20 mg  mL−1. The percentages of inhibition for 19 traditional Chi-
nese medicines are summarized in Table 1. The natural extract of
Fructus crataegi and Radix angelicae pubescentis were found to be
positive for enzyme inhibition by the presented method. The per-
centages of inhibition of Fructus crataegi a was 62.5.%. The value
was similar with the literature value obtained by EMMA technique
[30], in which, the percentages of inhibition of Fructus crataegi was
58.3%.
4. Conclusions
A method for preparing in-column TRS microreactor based on
LBL approach has been developed for screening enzyme inhibitors.
The method displays advantages including very low cost and
reusable enzyme, which not only saves on reagent costs but also
provides an unprecedented internal control in that the level of
enzyme is consistent for all assays. The performance and inhibition
kinetics of the immobilized TRS were studied. Extracts of 19 herbs
were tested and the ability for screening inhibitors in a complex
mixture can obviously improve the assay throughput.Acknowledgments
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